Krahasoni metodat

	Kurseshtimi i Shkurtër i Sëmundjeve Inflamatore Intestinale	Indeksi i Aktivitetit të Sëmundjes Crohn
Fusha	Gastroenterologji	Gastroenterologji
Familja	Process / pipeline	Process / pipeline
Viti i origjinës	2004	1976
Krijuesi	Guyonnet, D., Chassany, O., Ducroc, R., et al.	Best, W. R., Becktel, J. M., Singleton, J. W., and Kern, F.
Lloji	Self-report	Clinician-rated
Burimi themelues	Guyonnet, D., Chassany, O., Ducroc, R., Picard, C., Mouret, M., D'Haens, G., & Svartz, H. (2004). Effect of fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in France: A multicentre, randomized, double-blind, controlled trial. Alimentary Pharmacology & Therapeutics, 20(4), 459–465.	Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976). Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology, 70(3), 439–444.
Emërtime të tjera	IBDQ-32, Short IBDQ	CDAI
Të lidhura	4	4
Përmbledhja	The Short Inflammatory Bowel Disease Questionnaire (IBDQ-32) is a validated patient-reported outcome measure designed to assess the impact of inflammatory bowel disease (IBD)—both ulcerative colitis and Crohn's disease—on health-related quality of life. Derived from the original 32-item IBDQ, this instrument comprises four domains: Bowel Symptoms, Systemic Symptoms, Social Function, and Emotional Function. The IBDQ-32 is responsive to treatment and is increasingly used in IBD clinical trials and practice.	The Crohn's Disease Activity Index (CDAI) is a comprehensive, weighted index for assessing disease activity in Crohn's disease. Developed in 1976 by Best and colleagues for the National Cooperative Crohn's Disease Study, the CDAI integrates eight clinical and laboratory variables into a single score ranging from <150 (remission) to >450 (severe activity). Although more complex than symptom-based tools, the CDAI captures the multidimensional nature of Crohn's disease and remains the reference standard for severe disease assessment.